Ivacaftor (trade name Kalydeco) is a medication used to treat cystic fibrosis (CF) in people with certain gene mutations. It is a CFTR potentiator, a type of drug that increases the activity of the defective CFTR protein. Ivacaftor was developed by Vertex Pharmaceuticals and was the first approved medicine to treat the underlying cause of cystic fibrosis. It is approved for about 4% of people with CF, representing those with specific mutations in their CFTR gene. It is taken orally once a day. Common side effects include headache, upper respiratory tract infections, and diarrhea.
Ivacaftor, also commercially known as Kalydeco, is a prescription medication specifically used to treat cystic fibrosis (CF). Here's a breakdown of its key aspects:
Function:
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator: Ivacaftor belongs to a class of drugs called CFTR potentiators. Cystic fibrosis is caused by a genetic mutation in the CFTR protein, which disrupts the flow of fluids in the lungs and other organs. Ivacaftor works by improving the function of this specific protein.
Applications:
- Targeted Therapy: Ivacaftor is not a cure for cystic fibrosis, but it can significantly improve the condition in individuals with specific CFTR gene mutations that respond to this medication.
- Improves CF Symptoms: By enhancing CFTR function, Ivacaftor can help:
- Thin and loosen mucus in the lungs, easing breathing difficulties.
- Improve lung function.
- Reduce the frequency of lung infections.
Important Considerations:
- Genetic Testing Required: A doctor will perform a genetic test to determine if you have the specific mutations that respond to Ivacaftor treatment.
- Prescription Medication: Ivacaftor requires a doctor's prescription and close monitoring throughout therapy.
- Combination Therapy: Ivacaftor is often used in conjunction with other medications for comprehensive CF management.
- Potential Side Effects: Like any medication, Ivacaftor can cause side effects, including headache, rash, upper respiratory tract infections, and abdominal pain.